- Home
- ABTS vs MIRA Comparison
ABTS vs MIRA Comparison
Compare ABTS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- MIRA
- Stock Information
- Founded
- ABTS 2010
- MIRA 2020
- Country
- ABTS Hong Kong
- MIRA United States
- Employees
- ABTS N/A
- MIRA N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- ABTS Technology
- MIRA Health Care
- Exchange
- ABTS Nasdaq
- MIRA Nasdaq
- Market Cap
- ABTS 15.8M
- MIRA 17.1M
- IPO Year
- ABTS N/A
- MIRA 2023
- Fundamental
- Price
- ABTS $0.63
- MIRA $1.28
- Analyst Decision
- ABTS
- MIRA Strong Buy
- Analyst Count
- ABTS 0
- MIRA 2
- Target Price
- ABTS N/A
- MIRA $14.00
- AVG Volume (30 Days)
- ABTS 301.7K
- MIRA 3.5M
- Earning Date
- ABTS 12-03-2024
- MIRA 11-12-2024
- Dividend Yield
- ABTS N/A
- MIRA N/A
- EPS Growth
- ABTS N/A
- MIRA N/A
- EPS
- ABTS N/A
- MIRA N/A
- Revenue
- ABTS $5,343,888.00
- MIRA N/A
- Revenue This Year
- ABTS N/A
- MIRA N/A
- Revenue Next Year
- ABTS N/A
- MIRA N/A
- P/E Ratio
- ABTS N/A
- MIRA N/A
- Revenue Growth
- ABTS 3970.67
- MIRA N/A
- 52 Week Low
- ABTS $0.38
- MIRA $0.51
- 52 Week High
- ABTS $1.60
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- ABTS 59.34
- MIRA 40.18
- Support Level
- ABTS $0.53
- MIRA $1.13
- Resistance Level
- ABTS $0.65
- MIRA $1.58
- Average True Range (ATR)
- ABTS 0.09
- MIRA 0.19
- MACD
- ABTS 0.00
- MIRA -0.06
- Stochastic Oscillator
- ABTS 42.57
- MIRA 12.04
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.